Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 23, 2021

View Archived Issues

Noncanonical NLRC4 inflammasome mechanism offers new targets for sterile inflammatory disorders

SOCS1 is a major intracellular negative checkpoint of adoptive T-cell responses

Human mAbs prove a safe alternative to tetanus Ig for tetanus prevention and treatment in mice

Novel pleuromutilin derivatives with promising anti-MRSA activity

LAIR-1-targeting antibody NC-525 potentially effective against AML

Biomimetic synthesis of compounds from naturally abundant arglabin

SL-010110 inhibits gluconeogenesis and improves glucose homeostasis in diabetic mice

Topspin Therapeutics patents TMPRSS2 inhibitors

Autobahn Therapeutics divulges new thyromimetic compounds

Gilead Sciences identifies new LPAR1 antagonists

KSQ Therapeutics synthesizes USP1 inhibitors

Yumanity Therapeutics discloses PIKfyve inhibitors

Broader look reveals more contributions to chemotherapy damage

BiondVax signs agreements with Max Planck and UMG for COVID-19 NanoAbs

Novel aztreonam conjugates with promising activity against Gram-negative bacteria

Researchers present exosome-mediated system delivery of therapeutic cargo for HIV-1 repression

Claritas to develop R-107 for persistent pulmonary hypertension of the newborn

LogicBio nominates development candidate for treatment of hereditary tyrosinemia type 1

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...